BIOCON
Biocon Limited
Pharmaceuticals
Share price
₹364
Market cap
₹59,647 Cr
1Y return
▼ 8%
A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.
Investors holding Biocon Limited
9.18%
2.62%
2.57%
1.07%
Recent moves 53
Moves53
HDFC Life InsuranceExited
HDFC Life Insurance has vanished from the latest shareholder list for Biocon Limited, meaning the insurer either fully exited or trimmed its previous 1.01 percent holding below the 1 percent regulatory disclosure threshold.
Read more
LICDecreased
LIC decreased its stake in Biocon Limited from 3.73% to 2.62%, selling 1,80,81,115 shares.
Read more
Kotak Mutual FundIncreased
Kotak Mutual Fund increased its stake in Biocon Limited from 1.29% to 2.57%, acquiring 2,09,66,435 shares to bring its total holding to 4,19,58,298 shares.
Read more
SBI Mutual FundIncreased
SBI Mutual Fund increased its stake in Biocon Limited from 8.75% to 9.18%, purchasing 69,68,515 shares.
Read more
ICICI Prudential Mutual FundIncreased
ICICI Prudential Mutual Fund raised its stake in Biocon Limited from 1.46% to 4.07%, acquiring 4,25,49,395 shares.
Read more
HDFC Mutual FundNew position
HDFC Mutual Fund disclosed a 1.07% stake in Biocon Limited, holding 1,73,61,624 shares as of the latest shareholding update, up from under 1% in the prior quarter.
Read more
Kotak Mutual FundIncreased
Kotak Mutual Fund bought 12,77,000 shares of Biocon Limited for ₹49.16 Cr at ₹385.00 apiece in a block deal.
Read more
Government Pension Fund Global (Norway)New position
Government Pension Fund Global (Norway) bought 6,500,02 shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal on September 9, 2026.
Read more
Edelweiss Mutual FundNew position
Edelweiss Mutual Fund bought 6,50,002 shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal.
Read more
Societe GeneraleNew position
Societe Generale bought 6.5 lakh shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal.
Read more
Track the whales in Biocon Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1